However, recent advances in radiolabeled nanoparticles and CXCR4-targeted imaging agents already under evaluation in adult gliomas suggest promising avenues for precise, low-toxicity diagnosis and therapy in pediatric neuro-oncology [36]. Here, CXCR4 is linked to central nervous system cancer.